These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 16083526

  • 1. The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe.
    Reyderman L, Kosoglou T, Cutler DL, Maxwell S, Statkevich P.
    Curr Med Res Opin; 2005 Aug; 21(8):1171-9. PubMed ID: 16083526
    [Abstract] [Full Text] [Related]

  • 2. Pharmacodynamic interaction between ezetimibe and rosuvastatin.
    Kosoglou T, Statkevich P, Yang B, Suresh R, Zhu Y, Boutros T, Maxwell SE, Tiessen R, Cutler DL.
    Curr Med Res Opin; 2004 Aug; 20(8):1185-95. PubMed ID: 15324521
    [Abstract] [Full Text] [Related]

  • 3. Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin.
    Kosoglou T, Statkevich P, Meyer I, Cutler DL, Musiol B, Yang B, Zhu Y, Maxwell SE, Veltri EP.
    Curr Med Res Opin; 2004 Jun; 20(6):955-65. PubMed ID: 15200755
    [Abstract] [Full Text] [Related]

  • 4. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [Abstract] [Full Text] [Related]

  • 5. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.
    Ballantyne CM, Houri J, Notarbartolo A, Melani L, Lipka LJ, Suresh R, Sun S, LeBeaut AP, Sager PT, Veltri EP, Ezetimibe Study Group.
    Circulation; 2003 May 20; 107(19):2409-15. PubMed ID: 12719279
    [Abstract] [Full Text] [Related]

  • 6. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group.
    Clin Ther; 2004 Nov 20; 26(11):1758-73. PubMed ID: 15639688
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of fluvastatin alone or in combination with ezetimibe on lipoprotein subfractions in patients at high risk of coronary events.
    Stojakovic T, de Campo A, Scharnagl H, Sourij H, Schmölzer I, Wascher TC, März W.
    Eur J Clin Invest; 2010 Mar 20; 40(3):187-94. PubMed ID: 20067513
    [Abstract] [Full Text] [Related]

  • 8. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S, Gamez R, Mas R, Goicochea E.
    Int J Tissue React; 2003 Mar 20; 25(3):81-9. PubMed ID: 14756189
    [Abstract] [Full Text] [Related]

  • 9. Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.
    Bays H, Rhyne J, Abby S, Lai YL, Jones M.
    Curr Med Res Opin; 2006 Nov 20; 22(11):2191-200. PubMed ID: 17076980
    [Abstract] [Full Text] [Related]

  • 10. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T.
    Clin Ther; 2007 Nov 20; 29(11):2419-32. PubMed ID: 18158082
    [Abstract] [Full Text] [Related]

  • 11. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM.
    Curr Med Res Opin; 2006 Oct 20; 22(10):2041-53. PubMed ID: 17022864
    [Abstract] [Full Text] [Related]

  • 12. Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease.
    Farnier M, Volpe M, Massaad R, Davies MJ, Allen C.
    Int J Cardiol; 2005 Jul 10; 102(2):327-32. PubMed ID: 15982505
    [Abstract] [Full Text] [Related]

  • 13. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1994 Dec 10; (77):28-32. PubMed ID: 19496270
    [Abstract] [Full Text] [Related]

  • 14. Fluvastatin in combination with other lipid-lowering agents.
    Jokubaitis LA.
    Br J Clin Pract Suppl; 1996 Jan 10; 77A():28-32. PubMed ID: 8729588
    [Abstract] [Full Text] [Related]

  • 15. Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study.
    Knopp RH, Tsunehara C, Retzlaff BM, Fish B, Nguyen H, Anderson S, Nguyen T.
    Metabolism; 2006 Dec 10; 55(12):1697-703. PubMed ID: 17142146
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec 10; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 17. LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia.
    Brohet C, Banai S, Alings AM, Massaad R, Davies MJ, Allen C.
    Curr Med Res Opin; 2005 Apr 10; 21(4):571-8. PubMed ID: 15899106
    [Abstract] [Full Text] [Related]

  • 18. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial.
    Pearson TA, Denke MA, McBride PE, Battisti WP, Brady WE, Palmisano J.
    Mayo Clin Proc; 2005 May 10; 80(5):587-95. PubMed ID: 15887425
    [Abstract] [Full Text] [Related]

  • 19. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J, Hoffman R, Hanson M, Veltri E.
    Clin Ther; 2008 Dec 10; 30(12):2280-97. PubMed ID: 19167588
    [Abstract] [Full Text] [Related]

  • 20. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
    Geiss HC, Otto C, Parhofer KG.
    Metabolism; 2006 May 10; 55(5):599-604. PubMed ID: 16631435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.